sacituzumab govitecan bc cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
sacituzumab govitecan bc cancer	0.56	0.1	5798	94	31
sacituzumab	1.56	0.8	8910	20	11
govitecan	1.64	0.7	631	42	9
bc	1.04	0.7	9381	96	2
cancer	1.22	0.1	6057	22	6

Keyword	CPC	PCC	Volume	Score
sacituzumab govitecan bc cancer	1.19	0.2	4318	65
sacituzumab govitecan breast cancer	0.41	0.3	8517	56
sacituzumab govitecan lung cancer	0.97	1	6653	57
sacituzumab govitecan breast cancer approval	0.73	0.9	7299	90
sacituzumab govitecan for bladder cancer	1.05	0.6	9489	17
sacituzumab govitecan ovarian cancer	1.08	0.3	2220	16
sacituzumab govitecan patient information	1.37	0.9	7412	73
sacituzumab govitecan clinical trial	0.92	0.2	2101	10
is sacituzumab govitecan chemotherapy	0.85	0.5	9109	52
sacituzumab govitecan urothelial carcinoma	1.83	1	63	60
sacituzumab govitecan small cell lung cancer	1.91	0.3	7296	97
sacituzumab govitecan prescribing information	1.62	0.2	8294	30
sacituzumab-govitecan	1.85	0.5	882	63
sacituzumab govitecan fda approval	0.74	0.9	9205	96
sacituzumab govitecan fiche patient	1.28	0.3	4980	32
is sacituzumab govitecan immunotherapy	1.88	0.4	578	74
sacituzumab govitecan drug class	0.6	0.7	1645	45
sacituzumab govitecan plus pembrolizumab	0.58	0.2	6696	26
sacituzumab govitecan fda label	0.08	0.2	6700	85
sacituzumab govitecan protocol nhs	1.66	0.8	928	84
sacituzumab govitecan phase i	0.79	1	6677	94
acces precoce sacituzumab govitecan	0.35	0.9	8757	17
sacituzumab govitecan-hziy	1.67	0.2	4956	47